1. Home
  2. ASYS vs ADAG Comparison

ASYS vs ADAG Comparison

Compare ASYS & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

HOLD

Current Price

$16.66

Market Cap

233.5M

Sector

Technology

ML Signal

HOLD

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$3.54

Market Cap

254.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASYS
ADAG
Founded
1981
2011
Country
United States
China
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.5M
254.4M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
ASYS
ADAG
Price
$16.66
$3.54
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.25
AVG Volume (30 Days)
210.2K
356.5K
Earning Date
05-07-2026
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$79,364,000.00
N/A
Revenue This Year
$2.82
N/A
Revenue Next Year
$18.75
N/A
P/E Ratio
$1,677.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.35
$1.44
52 Week High
$19.74
$4.75

Technical Indicators

Market Signals
Indicator
ASYS
ADAG
Relative Strength Index (RSI) 58.84 42.78
Support Level $10.84 $3.49
Resistance Level $18.00 $3.53
Average True Range (ATR) 1.43 0.25
MACD 0.18 -0.07
Stochastic Oscillator 55.37 15.71

Price Performance

Historical Comparison
ASYS
ADAG

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

Share on Social Networks: